No Data
No Data
No Data
No Data
No Data
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today a
ArvinasApr 24 12:00
Analyst Forecasts For Arvinas, Inc. (NASDAQ:ARVN) Are Surging Higher
Arvinas, Inc. (NASDAQ:ARVN) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased their rev
Simply Wall StApr 18 03:58
Analysts' Top Healthcare Picks: Quanterix (QTRX), Intuitive Surgical (ISRG)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quanterix (QTRX), Intuitive Surgical (ISRG) and Arvinas Holding Company (ARVN) with bullish sentiments.
TipRanksApr 16 14:40
HC Wainwright & Co. : The Arvinas (ARVN.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $90.00 to $87.00.
HC Wainwright & Co. : The Arvinas (ARVN.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $90.00 to $87.00.
Zhitong FinanceApr 15 19:30
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Yahoo FinanceApr 13 01:55
Piper Sandler Sticks to Their Buy Rating for Arvinas Holding Company (ARVN)
TipRanksApr 12 20:29
No Data
No Data